What is the resting pacemaker potential in cardiac tissue (in mV)?
Which of the following disorders is LEAST likely to cause high output failure?
All of the following inflammatory mediators produce vasoconstriction except?
Alpha-methyldopa is primarily used for which of the following conditions?
A 55-year-old man has been diagnosed with Stokes-Adams syndrome. Two minutes after the onset of a syncopal attack, which of the following is the pacemaker of the heart?
What is the single most important factor in the control of automatic contractility of the heart?
Distribution of blood flow is mainly regulated by?
The chemoreceptor reflex primarily causes which of the following physiological responses?
On increasing vagal tone, what occurs in the pacemaker?
Increased blood pressure and decreased heart rate is seen in which of the following conditions?
Explanation: **Explanation:** The resting membrane potential (RMP) of the cardiac pacemaker (SA node) is approximately **-55 to -60 mV**. Unlike ventricular myocytes, pacemaker cells lack a stable resting potential; instead, they exhibit a slow, spontaneous depolarization known as the "pacemaker potential" or Phase 4. **Why -55 mV is correct:** In the SA node, the RMP is less negative than in other cardiac tissues because the cell membranes are naturally leakier to sodium and calcium ions. This higher baseline potential is crucial because it keeps the fast sodium channels permanently inactivated, making the upstroke of the action potential dependent on slower calcium channels (L-type). **Analysis of Incorrect Options:** * **-40 mV:** This is the **threshold potential** for the SA node. Once the slow depolarization reaches this level, voltage-gated L-type calcium channels open, triggering the action potential. * **-70 mV:** This is the typical RMP for neurons or certain specialized conducting tissues like the Bundle of His, but it is too negative for the SA node. * **-90 mV:** This is the RMP for **ventricular muscle fibers** and Purkinje fibers. It is maintained by a high resting permeability to potassium ($K^+$) and is necessary for the rapid depolarization (Phase 0) mediated by fast sodium channels. **High-Yield Clinical Pearls for NEET-PG:** 1. **Funny Currents ($I_f$):** The initial phase of pacemaker depolarization is caused by $I_f$ channels, which are activated by hyperpolarization and carry sodium ions. 2. **Pre-potential:** The slope of Phase 4 determines the heart rate. Acetylcholine (vagus nerve) decreases this slope (bradycardia), while Norepinephrine increases it (tachycardia). 3. **Hierarchy:** The SA node is the primary pacemaker because it has the highest intrinsic rate of spontaneous depolarization (60-100 bpm).
Explanation: **Explanation:** High-output heart failure (HOHF) occurs when the heart's cardiac output is elevated but still fails to meet the metabolic demands of the body, or can only do so at the expense of elevated filling pressures. This is typically driven by a decrease in **Systemic Vascular Resistance (SVR)** or an increase in metabolic rate. **Why Addison Disease is the Correct Answer:** Addison disease (primary adrenal insufficiency) is characterized by a deficiency in mineralocorticoids and glucocorticoids. This leads to **hypovolemia** (due to salt wasting), decreased vascular tone, and reduced cardiac contractility. Consequently, patients present with **low cardiac output** and hypotension, making it the "least likely" to cause a high-output state. **Analysis of Incorrect Options:** * **Thiamine Deficiency (Wet Beriberi):** Thiamine is a cofactor for carbohydrate metabolism. Deficiency leads to peripheral vasodilation and increased venous return, causing classic HOHF. * **Hyperthyroidism:** Excess thyroid hormones increase metabolic demand, induce peripheral vasodilation, and have direct positive inotropic/chronotropic effects on the heart, significantly raising cardiac output. * **Paget Disease of Bone:** Extensive remodeling of bone involves the formation of multiple **microscopic arteriovenous (AV) shunts**. These shunts bypass the capillary beds, decreasing SVR and increasing venous return to the heart. **NEET-PG High-Yield Pearls:** * **Common causes of HOHF:** Anemia, Pregnancy, AV Fistulas, Beriberi, Hyperthyroidism, and Paget’s disease. * **Hemodynamic Hallmark:** Decreased SVR + Increased Cardiac Index. * **Clinical Sign:** "Warm failure" (warm extremities and bounding pulses), unlike the "cold failure" seen in typical low-output states.
Explanation: **Explanation:** The core concept tested here is the distinction between **vasoconstrictors** and **vasodilators** released during inflammation and vascular injury. **Why Bradykinin is the correct answer:** Bradykinin is a potent **vasodilator**. It acts by stimulating the release of nitric oxide (NO) and prostacyclin ($PGI_2$) from the vascular endothelium. In the context of inflammation, Bradykinin increases capillary permeability and is a primary mediator of pain (by sensitizing nociceptors). Because it causes vasodilation rather than constriction, it is the correct "except" choice. **Analysis of Incorrect Options:** * **Endothelin-1:** This is the most potent endogenous **vasoconstrictor** known. It is produced by damaged endothelial cells and plays a significant role in maintaining vascular tone and the pathophysiology of pulmonary hypertension. * **Thromboxane A2 ($TXA_2$):** Produced by activated platelets, $TXA_2$ is a powerful **vasoconstrictor** and platelet aggregator. It works in opposition to Prostacyclin ($PGI_2$) to limit blood loss during injury. * **Platelet Activating Factor (PAF):** While PAF has complex systemic effects (including bronchoconstriction), at the local site of injury/inflammation, it can induce **vasoconstriction** and increase vascular permeability. **NEET-PG High-Yield Pearls:** * **Triple Response of Lewis:** Bradykinin and Histamine are key mediators of the "Flare" (vasodilation) component. * **ACE Inhibitors:** These drugs prevent the breakdown of Bradykinin. Elevated levels of Bradykinin are responsible for the common side effects of ACE inhibitors: **dry cough** and **angioedema**. * **Vasoconstrictor Mnemonic:** Remember **"SET"** (Serotonin, Endothelin, Thromboxane $A_2$).
Explanation: **Explanation:** **Alpha-methyldopa** is a centrally acting sympatholytic agent. It acts as a prodrug, converted into **alpha-methylnorepinephrine**, which stimulates central **alpha-2 adrenergic receptors** in the nucleus tractus solitarius. This stimulation decreases sympathetic outflow to the heart and peripheral vasculature, leading to a reduction in blood pressure. **Why Option A is Correct:** Alpha-methyldopa is the **drug of choice for Pregnancy-Induced Hypertension (PIH)** and chronic hypertension in pregnancy. It has a long-standing safety record with no evidence of teratogenicity and does not compromise uteroplacental blood flow, making it safe for both the mother and the fetus. **Why Other Options are Incorrect:** * **Option B (Renovascular Hypertension):** This condition is typically managed with ACE inhibitors or ARBs (unless bilateral) or surgical intervention. Methyldopa is not the primary treatment. * **Option C (First-line agent):** In the general population, ACE inhibitors, ARBs, Calcium Channel Blockers (CCBs), or Thiazide diuretics are first-line agents. Methyldopa is rarely used as a first-line drug outside of pregnancy due to its side-effect profile. * **Option D (Refractory Hypertension):** Refractory or resistant hypertension usually requires a combination of potent diuretics, vasodilators (like Minoxidil), or Spironolactone. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** The most characteristic side effect is a **positive Direct Coombs Test**, which can occasionally lead to autoimmune hemolytic anemia. * **Other Side Effects:** Sedation (most common), "Lupus-like" reaction, and drug-induced hepatitis. * **Other safe drugs in pregnancy:** **L**abetalol (often preferred in acute settings), **N**ifedipine, and **H**ydralazine (Mnemonic: **L**ittle **M**others **N**eed **H**elp). * **Contraindication:** Avoid ACE inhibitors and ARBs in pregnancy due to risk of fetal renal dysgenesis.
Explanation: ### Explanation **Underlying Medical Concept: Ventricular Escape Rhythm** Stokes-Adams syndrome refers to sudden, transient episodes of syncope caused by a complete heart block (Third-degree AV block). When the conduction between the atria and ventricles is interrupted, the ventricles stop contracting for 5 to 30 seconds because they were previously "overdrive suppressed" by the rapid sinus rhythm. After this delay, a distal part of the conduction system—specifically the **Purkinje fibers**—begins to discharge spontaneously. This is known as **ventricular escape rhythm**, which typically occurs at a rate of 15–40 beats per minute, restoring cerebral blood flow. **Analysis of Options:** * **Purkinje fibers (Correct):** These possess intrinsic automaticity. In the event of a complete AV block, they act as the tertiary pacemaker to prevent permanent cardiac standstill. * **Sinus node (Incorrect):** While the SA node continues to fire and depolarize the atria, the electrical impulse cannot cross the AV node to reach the ventricles; thus, it cannot function as the ventricular pacemaker. * **A-V node (Incorrect):** In Stokes-Adams syndrome, the block is often located within the AV bundle (Bundle of His) or distal to it. Therefore, the AV node cannot bypass the block to pace the ventricles. * **Cardiac septum (Incorrect):** The septum is myocardial tissue. While it can conduct impulses, it does not possess the specialized rhythmic pacemaking cells required to initiate a stable escape rhythm. **NEET-PG High-Yield Pearls:** * **Overdrive Suppression:** The mechanism where a faster pacemaker (SA node) inhibits the automaticity of slower latent pacemakers. * **Intrinsic Rates:** SA node (60–100 bpm) > AV node (40–60 bpm) > Purkinje system (15–40 bpm). * **Clinical Presentation:** The "syncopal attack" occurs during the delay between the block and the onset of the Purkinje rhythm. If the delay is too long, it can be fatal.
Explanation: **Explanation:** The correct answer is **Sympathetic stimulation**. **1. Why Sympathetic Stimulation is Correct:** The heart’s contractility (inotropy) is primarily regulated by the autonomic nervous system. Sympathetic fibers release **Norepinephrine**, which binds to **$\beta_1$ receptors** on the myocardium. This triggers the Gs-protein-adenylyl cyclase-cAMP pathway, leading to the activation of Protein Kinase A (PKA). PKA phosphorylates L-type calcium channels and phospholamban, resulting in increased calcium influx and faster calcium reuptake. This increases the force of contraction (positive inotropy) and the rate of relaxation (positive lusitropy), making it the most potent extrinsic regulator of cardiac contractility. **2. Why the Other Options are Incorrect:** * **Myocardial wall thickness (A):** While thickness relates to the Law of Laplace and total force generation, it is a structural adaptation (hypertrophy) rather than a dynamic control factor for automatic contractility. * **Right atrial volume (B):** This relates to the **Frank-Starling Law** (intrinsic regulation). While increased volume increases stroke volume via stretch, it is considered "preload-dependent" rather than a change in the "automatic contractility" (inotropic state) of the muscle itself. * **SA node pacemaker potential (C):** This determines the **heart rate (chronotropy)**, not the force of contraction (inotropy). **High-Yield Clinical Pearls for NEET-PG:** * **Parasympathetic (Vagal) Effect:** The Vagus nerve has a significant negative chronotropic effect but a **minimal** effect on ventricular contractility due to sparse innervation of the ventricles. * **Bowditch Effect (Treppe Phenomenon):** An intrinsic increase in contractility observed when the heart rate increases. * **Digitalis Mechanism:** Increases contractility by inhibiting the $Na^+$-$K^+$ ATPase pump, indirectly increasing intracellular $Ca^{2+}$.
Explanation: **Explanation:** The **arterioles** are known as the **"resistance vessels"** of the cardiovascular system and are the primary site for regulating blood flow distribution. **1. Why Arterioles are Correct:** Arterioles possess a thick layer of smooth muscle in their walls relative to their lumen size. This allows them to undergo significant changes in diameter through vasoconstriction and vasodilation. According to **Poiseuille’s Law**, resistance is inversely proportional to the fourth power of the radius ($R \propto 1/r^4$). Therefore, even small changes in arteriolar diameter result in massive changes in vascular resistance, allowing the body to precisely divert blood flow to specific organs based on metabolic demand (e.g., shunting blood to muscles during exercise). **2. Why Other Options are Incorrect:** * **Arteries:** These are "conduit vessels." While they have elastic properties to dampen pressure pulses (Windkessel effect), they do not provide the high resistance necessary to regulate specific organ perfusion. * **Capillaries:** These are "exchange vessels." Although they are the narrowest, they lack smooth muscle and cannot actively contract to regulate flow. Their total cross-sectional area is the highest, resulting in the slowest blood flow velocity. * **Venules:** These are "capacitance vessels." Along with veins, they store approximately 60-70% of the total blood volume but play a minimal role in regulating the distribution of arterial flow. **Clinical Pearls for NEET-PG:** * **Highest Resistance:** Arterioles (site of maximum peripheral resistance). * **Highest Pressure Drop:** Occurs across the arterioles. * **Velocity of Flow:** Lowest in the capillaries (facilitates nutrient exchange). * **Total Cross-sectional Area:** Highest in the capillaries.
Explanation: ### Explanation The **Peripheral Chemoreceptor Reflex** is primarily triggered by hypoxia ($PO_2 < 60$ mmHg), hypercapnia, and acidosis. These receptors are located in the **Carotid bodies** (via Glossopharyngeal nerve) and **Aortic bodies** (via Vagus nerve). **1. Why Option B is Correct:** The primary (direct) response of chemoreceptor stimulation involves two main components: * **Vasoconstriction:** Stimulation of the vasomotor center in the medulla leads to intense peripheral vasoconstriction (via sympathetic outflow) to maintain blood pressure and prioritize flow to the brain and heart. * **Bradycardia:** The direct effect of chemoreceptor stimulation on the medullary vagal center is inhibitory to the heart rate. * *Note:* While the secondary response (due to increased respiration and the Hering-Breuer reflex) often results in tachycardia in a conscious, breathing human, the **primary physiological reflex**—and the one typically tested in exams—is **bradycardia and vasoconstriction**. **2. Why Other Options are Wrong:** * **Options A & D (Vasodilation):** Chemoreceptors always trigger vasoconstriction to compensate for low oxygen states; vasodilation would cause a catastrophic drop in blood pressure. * **Option C (Tachycardia):** While tachycardia occurs *secondarily* due to increased lung stretch and sympathetic activation from respiratory distress, the *direct* reflex action of the chemoreceptor on the cardiac centers is bradycardia. **3. High-Yield Facts for NEET-PG:** * **Location:** Carotid bodies are the most sensitive; they have the highest blood flow per gram of tissue in the body. * **Threshold:** Peripheral chemoreceptors only respond when $PaO_2$ falls below **60 mmHg**. * **Central vs. Peripheral:** Central chemoreceptors (Medulla) respond to $H^+$ changes in CSF (driven by $CO_2$) but **do not** respond to hypoxia. Hypoxia is sensed **only** by peripheral chemoreceptors. * **Cushing’s Triad:** Do not confuse this with the chemoreceptor reflex. Cushing’s (increased ICP) presents with Hypertension, Bradycardia, and Irregular Respiration.
Explanation: ### Explanation **Mechanism of Vagal Action on the Pacemaker** The Vagus nerve (Parasympathetic nervous system) releases **Acetylcholine (ACh)**, which acts on **M2 receptors** in the SA node. This triggers two primary ionic changes: 1. **Increased K+ conductance:** ACh activates G protein-coupled inward rectifier potassium channels ($K_{ACh}$), leading to **increased K+ efflux**. This causes hyperpolarization of the resting membrane potential. 2. **Decreased Funny Current ($I_f$) and Calcium Current ($I_{Ca}$):** This reduces the rate of sodium and calcium influx during the prepotential phase. The net result of these changes is a **decreased slope of Phase 4 depolarization** (prepotential). A flatter slope means it takes longer for the membrane potential to reach the threshold, thereby decreasing the heart rate (negative chronotropy). **Analysis of Options:** * **Option C (Correct):** Increased K+ efflux (hyperpolarization) combined with reduced inward currents results in a **decreased slope of Phase 4**. * **Option A & D:** An increased slope of Phase 4 is a feature of Sympathetic stimulation (Catecholamines), which increases heart rate. * **Option B:** While the slope decreases, it is caused by *increased* K+ efflux, not decreased. **High-Yield NEET-PG Pearls:** * **Phase 4 (Prepotential):** The unstable resting membrane potential responsible for automaticity. * **Ionic Basis of Phase 4:** Primarily due to $I_f$ (Funny current/HCN channels), $I_{Ca-T}$ (T-type Ca channels), and $I_{Ca-L}$ (L-type Ca channels). * **Vagal Effect:** Decreases heart rate (Chronotropy) and dromotropy (AV conduction velocity) but has minimal effect on ventricular contractility (Inotropy). * **Atropine:** A muscarinic antagonist used to treat bradycardia by blocking these vagal effects.
Explanation: ### Explanation The combination of **increased blood pressure (hypertension)** and **decreased heart rate (bradycardia)** is a classic physiological phenomenon known as the **Cushing Reflex**, which occurs in response to **Raised Intracranial Pressure (RICP)**. **1. Why Raised Intracranial Pressure is Correct:** When ICP increases, it compresses cerebral blood vessels, leading to cerebral ischemia. To maintain cerebral perfusion, the vasomotor center in the medulla triggers a massive sympathetic discharge, increasing systemic blood pressure (Hypertension). This high systemic pressure is sensed by baroreceptors in the carotid sinus and aortic arch, which then trigger a compensatory parasympathetic (vagal) response, resulting in a reflex decrease in heart rate (Bradycardia). **2. Why the Other Options are Incorrect:** * **Hemorrhage:** Leads to hypovolemia, resulting in **decreased BP** and a compensatory **increased HR** (tachycardia) to maintain cardiac output. * **High Altitude:** Hypoxia at high altitudes stimulates the peripheral chemoreceptors, leading to an **increase in HR** and respiratory rate. * **Anemia:** To compensate for the reduced oxygen-carrying capacity of the blood, the body increases cardiac output by **increasing the HR** (hyperdynamic circulation). **3. Clinical Pearls for NEET-PG:** * **Cushing’s Triad:** A late sign of brain herniation consisting of: 1. Hypertension (with widened pulse pressure) 2. Bradycardia 3. Irregular respirations (Cheyne-Stokes breathing) * **Baroreceptor Reflex:** This is the underlying mechanism for the "reflex bradycardia" seen after the initial hypertensive surge in RICP. * **Contrast:** Remember that in most forms of shock (except neurogenic), BP and HR move in opposite directions (Low BP, High HR). In RICP, they also move in opposite directions, but the BP is High and HR is Low.
Cardiac Electrophysiology
Practice Questions
Cardiac Cycle
Practice Questions
Cardiac Output and Its Regulation
Practice Questions
Hemodynamics and Blood Flow
Practice Questions
Arterial System Physiology
Practice Questions
Microcirculation and Lymphatics
Practice Questions
Venous Return and Central Venous Pressure
Practice Questions
Cardiovascular Reflexes
Practice Questions
Regional Circulations
Practice Questions
Cardiovascular Responses to Exercise and Stress
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free